Literature DB >> 33760672

Eupnea and gasping in vivo are facilitated by the activation of 5-HT2A receptors.

Kevin J Cummings1.   

Abstract

Eupnea and gasping in infancy depend on central nervous system (CNS) serotonin (5-hydroxytryptamine; 5-HT). Although previous in vitro preparations have provided some evidence that 5-HT acts through type 2 A receptors (5-HT2A) to facilitate eupnea and gasping, here the hypothesis addressed is that 5-HT2A receptor activation is necessary for eupnea and the proper generation of gasping in vivo. To test this, we administered 2,5-dimethoxy-4-iodoamphetamine (DOI; 0.25 mg/kg i.p.), a 5-HT2A agonist, 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT; 0.25 mg/kg i.p.), a 5-HT1A agonist, or vehicle (saline) to 7-9-day-old tryptophan hydroxylase 2 knockout (TPH2-/-) mice. A second experiment assessed the effect of MDL-11,939 (MDL; 10 mg/kg i.p.), the specific 5-HT2A antagonist, or vehicle (DMSO) on the gasping of wild-type (TPH2+/+) animals. Drugs were given 15 min prior to five episodes of severe hypoxia that elicited gasping. TPH2-/- breathed more slowly but had the same V̇e and V̇e/V̇o2 compared with TPH2+/+. As previously reported, the gasping of TPH2-/- was significantly delayed (P < 0.001) and occurred at a significantly lower frequency compared with TPH2+/+ (P = 0.04). For both genotypes, DOI hastened eupneic frequency but had no effect on V̇e or V̇e/V̇o2. The gasping of TPH2-/-, although unaffected by 8-OH-DPAT, was indistinguishable from the gasping of TPH2+/+ following DOI. In TPH2+/+, application of MDL led to hypoventilation (P = 0.01), a delay in the appearance of gasping (P = 0.005), and reduced gasp frequency (P = 0.05). These data show that, in vivo, 5-HT2A receptors facilitate both eupnea and gasping. As has been shown in vitro, 5-HT2A probably promotes gasping by exciting hypoxia-resistant pacemaker neurons.NEW & NOTEWORTHY Previous in vitro studies suggest that 5-HT2A receptors contribute to eupnea and are necessary for fictive gasping. The current study shows that the impaired gasping displayed by neonatal TPH2-/- mice, deficient in CNS serotonin, is restored by 5-HT2A receptor activation. Following 5-HT2A blockade, wild-type mice hypoventilated and their gasping resembled that of TPH2-/- mice. This study shows that both eupnea and gasping in vivo rely on the activation of 5-HT2A receptors.

Entities:  

Keywords:  5-HT2 receptors; eupnea; gasping; respiratory rhythm; serotonin

Mesh:

Substances:

Year:  2021        PMID: 33760672      PMCID: PMC8356760          DOI: 10.1152/jn.00088.2021

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  39 in total

1.  Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, -HT(2B) and 5-HT2C receptors.

Authors:  D L Nelson; V L Lucaites; D B Wainscott; R A Glennon
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1999-01       Impact factor: 3.000

2.  Dual serotonergic regulation of ventricular contractile force through 5-HT2A and 5-HT4 receptors induced in the acute failing heart.

Authors:  Eirik Qvigstad; Ivar Sjaastad; Trond Brattelid; Caroline Nunn; Fredrik Swift; Jon Arne Kro Birkeland; Kurt A Krobert; Geir Øystein Andersen; Ole M Sejersted; Jan-Bjørn Osnes; Finn Olav Levy; Tor Skomedal
Journal:  Circ Res       Date:  2005-07-07       Impact factor: 17.367

3.  Distribution of serotonin-immunoreactivity in the central nervous system of the rat-cell bodies and terminals.

Authors:  H W Steinbusch
Journal:  Neuroscience       Date:  1981       Impact factor: 3.590

4.  Failed heart rate recovery at a critical age in 5-HT-deficient mice exposed to episodic anoxia: implications for SIDS.

Authors:  Kevin J Cummings; Kathryn G Commons; Julie C Hewitt; John A Daubenspeck; Aihua Li; Hannah C Kinney; Eugene E Nattie
Journal:  J Appl Physiol (1985)       Date:  2011-06-16

5.  Multiple serotonergic brainstem abnormalities in sudden infant death syndrome.

Authors:  David S Paterson; Felicia L Trachtenberg; Eric G Thompson; Richard A Belliveau; Alan H Beggs; Ryan Darnall; Amy E Chadwick; Henry F Krous; Hannah C Kinney
Journal:  JAMA       Date:  2006-11-01       Impact factor: 56.272

6.  Maintenance of gasping and restoration of eupnea after hypoxia is impaired following blockers of alpha1-adrenergic receptors and serotonin 5-HT2 receptors.

Authors:  Walter M St-John; J C Leiter
Journal:  J Appl Physiol (1985)       Date:  2007-12-27

7.  Transgenic mice lacking serotonin neurons have severe apnea and high mortality during development.

Authors:  Matthew R Hodges; Mackenzie Wehner; Jason Aungst; Jeffrey C Smith; George B Richerson
Journal:  J Neurosci       Date:  2009-08-19       Impact factor: 6.167

8.  Serotonin increases L-type Ca2+ current and SR Ca2+ content through 5-HT4 receptors in failing rat ventricular cardiomyocytes.

Authors:  Jon Arne Kro Birkeland; Fredrik Swift; Nils Tovsrud; Ulla Enger; Per Kristian Lunde; Eirik Qvigstad; Finn Olav Levy; Ole M Sejersted; Ivar Sjaastad
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-07-27       Impact factor: 4.733

9.  A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure.

Authors:  Vijay K Yadav; Franck Oury; Nina Suda; Zhong-Wu Liu; Xiao-Bing Gao; Cyrille Confavreux; Kristen C Klemenhagen; Kenji F Tanaka; Jay A Gingrich; X Edward Guo; Laurence H Tecott; J John Mann; Rene Hen; Tamas L Horvath; Gerard Karsenty
Journal:  Cell       Date:  2009-09-04       Impact factor: 41.582

10.  Effects of serotonin 5-HT(2A/2C) antagonists on associative learning in the rabbit.

Authors:  S E Welsh; A G Romano; J A Harvey
Journal:  Psychopharmacology (Berl)       Date:  1998-05       Impact factor: 4.530

View more
  1 in total

1.  Current research in pathophysiology of opioid-induced respiratory depression, neonatal opioid withdrawal syndrome, and neonatal antidepressant exposure syndrome.

Authors:  Brian A Baldo
Journal:  Curr Res Toxicol       Date:  2022-06-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.